124 related articles for article (PubMed ID: 4348798)
21. An immuno-electron microscopic analysis of Epstein-Barr virus-related antigens in Burkitt lymphoma cells.
Suzuki I
Gan; 1972 Oct; 63(5):629-31. PubMed ID: 4345632
[No Abstract] [Full Text] [Related]
22. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
[TBL] [Abstract][Full Text] [Related]
23. Investigations of the presence of serum antibodies to Epstein-Barr virus in patients with various tumors.
Pătraşcu IV; Mihăilescu D; Nicolae I; Andrian T; Grigoriu G; Iost A
Virologie; 1980; 31(4):279-81. PubMed ID: 6266130
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies.
Reedman BM; Klein G; Pope JH; Walters MK; Hilgers J; Singh S; Johansson B
Int J Cancer; 1974 Jun; 13(6):755-63. PubMed ID: 4136722
[No Abstract] [Full Text] [Related]
25. [Immunologic tests: Epstein-Barr virus].
Mizuno F
Nihon Rinsho; 2005 Jul; 63 Suppl 7():300-3. PubMed ID: 16111256
[No Abstract] [Full Text] [Related]
26. Observations on the antigenic relationships between Epstein-Barr virus and herpesvirus saimiri.
Morgan DG
J Gen Virol; 1977 Aug; 36(2):281-7. PubMed ID: 70507
[TBL] [Abstract][Full Text] [Related]
27. [Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases].
Gunven P
G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(9):228-32. PubMed ID: 4353758
[No Abstract] [Full Text] [Related]
28. [Immunology of Epstein-Barr virus in lymphoproliferative diseases].
Bachmann AE; Giraudo Conesa LC; Braun M
Medicina (B Aires); 1974 Mar; 34(2):157-66. PubMed ID: 4368156
[No Abstract] [Full Text] [Related]
29. Radioiodine-labeled antibody test for the detection of membrane antigens associated with Epstein-Barr virus.
Hewetson JF; Gothoskar B; Klein G
J Natl Cancer Inst; 1972 Jan; 48(1):87-94. PubMed ID: 4347031
[No Abstract] [Full Text] [Related]
30. High titer of antibody to the Epstein-Barr virus membrane antigen in sera from patients with rheumatoid arthritis and systemic lupus erythematosus.
Yokochi T; Yanagawa A; Kimura Y; Mizushima Y
J Rheumatol; 1989 Aug; 16(8):1029-32. PubMed ID: 2555505
[TBL] [Abstract][Full Text] [Related]
31. Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti-MA).
de Schryver A; Klein G; Hewetson J; Rocchi G; Henle W; Henle G; Moss DJ; Pope JH
Int J Cancer; 1974 Mar; 13(3):353-62. PubMed ID: 4362610
[No Abstract] [Full Text] [Related]
32. Epstein-Barr virus-associated antigens in non-producing clones of human lymphoblastoid cell lines.
Sugawara K; Mizuno F; Osato T
Nat New Biol; 1972 Oct; 239(95):242-3. PubMed ID: 4343346
[No Abstract] [Full Text] [Related]
33. Production of infective Epstein-Barr virus in a Burkitt lymphoma cell line, P3HR-1.
Nagoya T; Hinuma Y
Gan; 1972 Feb; 63(1):87-93. PubMed ID: 4339714
[No Abstract] [Full Text] [Related]
34. Antibodies to Epstein-Barr-virus antigens before and after the development of Burkitt's lymphoma in a patient treated for Hodgkin's disease.
Magrath I; Henle W; Owor R; Olweny C
N Engl J Med; 1975 Mar; 292(12):621-3. PubMed ID: 163432
[No Abstract] [Full Text] [Related]
35. Association of Epstein-Barr viral genomes with American Burkitt lymphoma.
Andersson M; Klein G; Zeigler JL; Henle W
Nature; 1976 Mar; 260(5549):357-9. PubMed ID: 176599
[No Abstract] [Full Text] [Related]
36. Modes of Epstein-Barr virus infection in human floating cell lines.
Sairenji T; Hinuma Y
Gan; 1973 Dec; 64(6):583-90. PubMed ID: 4360583
[No Abstract] [Full Text] [Related]
37. Antibodies to Epstein-Barr virus (EBV) antigens in sera of American Burkitt lymphoma patients.
Ablashi DV; De-Thé GB; Easton JM; Liabeuf A; Levine PH; Armstrong GR
Biomedicine; 1974 Jul; 21(7):288-93. PubMed ID: 4139981
[No Abstract] [Full Text] [Related]
38. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.
Miller G; Lipman M
Proc Natl Acad Sci U S A; 1973 Jan; 70(1):190-4. PubMed ID: 4346033
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus (EBV). IV. Studies on experimental inactivated vaccine against human EBV infection.
Pătraşcu IV; Tache M
Virologie; 1988; 39(1):29-33. PubMed ID: 2837001
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity of Epstein-Barr virus. II. Induction of early antigens (EA) by complementation.
zur Hausen H; Fresen KO
Virology; 1977 Aug; 81(1):138-43. PubMed ID: 196397
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
